Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder

NCT00685113 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.

NCT NCT00685113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00685113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder
Lead sponsor
Duramed Research
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
March 31, 2010
Enrollment
1,104 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder